Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M163,117Revenue $M11,202Net Margin (%)45.5Z-Score9.2
Enterprise Value $M166,508EPS $1.8Operating Margin %58.6F-Score8
P/E(ttm))19.1Cash Flow Per Share $4.3Pre-tax Margin (%)56.7Higher ROA y-yY
Price/Book12.110-y EBITDA Growth Rate %0Quick Ratio1.8Cash flow > EarningsY
Price/Sales8.75-y EBITDA Growth Rate %8.2Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow17.4y-y EBITDA Growth Rate %176ROA % (ttm)35.3Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)72.0Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,509ROI % (ttm)15.0Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDRonald Muhlenkamp 2014-09-30 Add1.19%$85.07 - $109.43
($97.98)
$ 105.548%Add 42.59%206,350
GILDJoel Greenblatt 2014-09-30 Add0.21%$85.07 - $109.43
($97.98)
$ 105.548%Add 42.28%664,223
GILDDavid Dreman 2014-09-30 Buy 0.02%$85.07 - $109.43
($97.98)
$ 105.548%New holding, 2388 sh.2,388
GILDJohn Burbank 2014-09-30 Add0.01%$85.07 - $109.43
($97.98)
$ 105.548%Add 219.9%12,073
GILDDodge & Cox 2014-09-30 Buy $85.07 - $109.43
($97.98)
$ 105.548%New holding, 4800 sh.4,800
GILDKen Heebner 2014-09-30 Reduce-0.33%$85.07 - $109.43
($97.98)
$ 105.548%Reduce -8.77%1,560,000
GILDVanguard Health Care Fund 2014-09-30 Reduce-0.28%$85.07 - $109.43
($97.98)
$ 105.548%Reduce -76.79%379,200
GILDRay Dalio 2014-09-30 Reduce-0.07%$85.07 - $109.43
($97.98)
$ 105.548%Reduce -30.96%241,521
GILDKen Fisher 2014-09-30 Reduce-0.04%$85.07 - $109.43
($97.98)
$ 105.548%Reduce -21.74%763,423
GILDKen Heebner 2014-06-30 Buy 3.8%$65.48 - $83.02
($77.76)
$ 105.5436%New holding, 1710000 sh.1,710,000
GILDJulian Robertson 2014-06-30 Add2.98%$65.48 - $83.02
($77.76)
$ 105.5436%Add 28.55%443,911
GILDJoel Greenblatt 2014-06-30 Buy 0.48%$65.48 - $83.02
($77.76)
$ 105.5436%New holding, 466853 sh.466,853
GILDJohn Rogers 2014-06-30 Add0.25%$65.48 - $83.02
($77.76)
$ 105.5436%Add 60.78%638,734
GILDKen Fisher 2014-06-30 Add0.07%$65.48 - $83.02
($77.76)
$ 105.5436%Add 62.11%975,483
GILDRay Dalio 2014-06-30 Add0.06%$65.48 - $83.02
($77.76)
$ 105.5436%Add 41.22%349,821
GILDRonald Muhlenkamp 2014-06-30 Reduce-0.59%$65.48 - $83.02
($77.76)
$ 105.5436%Reduce -24.63%144,715
GILDVanguard Health Care Fund 2014-06-30 Reduce-0.21%$65.48 - $83.02
($77.76)
$ 105.5436%Reduce -39.79%1,633,700
GILDGeorge Soros 2014-06-30 Sold Out -0.04%$65.48 - $83.02
($77.76)
$ 105.5436%Sold Out0
GILDMariko Gordon 2014-06-30 Reduce-0.02%$65.48 - $83.02
($77.76)
$ 105.5436%Reduce -35.57%11,654
GILDJulian Robertson 2014-03-31 Add0.59%$68.55 - $83.95
($78.44)
$ 105.5434%Add 7.91%345,320
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GILD David Dreman 2014-09-302,38800.02New Buy
GILD Dodge & Cox 2014-09-304,80000New Buy
GILD John Burbank 2014-09-3012,07300.02+219.9%
GILD Ronald Muhlenkamp 2014-09-30206,3500.014+42.59%
GILD Joel Greenblatt 2014-09-30664,2230.040.7+42.28%
GILD John Rogers 2014-09-30643,8960.040.88+0.81%
GILD Julian Robertson 2014-09-30443,9110.0312.5
GILD Jean-Marie Eveillard 2014-09-3040000
GILD Ken Heebner 2014-09-301,560,0000.14.7-8.77%
GILD Mariko Gordon 2014-09-3010,36600.05-11.05%
GILD Mario Gabelli 2014-09-3042,60000.02-13.36%
GILD Ken Fisher 2014-09-30763,4230.050.17-21.74%
GILD Ray Dalio 2014-09-30241,5210.020.2-30.96%
GILD Vanguard Health Care Fund 2014-09-30379,2000.030.1-76.79%
Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLIGAN JOHN FPresident and COO 2014-12-08Sell146,823$106.26-5.46view
MARTIN JOHN CChairman and CEO 2014-12-01Sell140,633$100.72-0.26view
Alton Gregg HEVP, Corp & Med Affairs 2014-12-01Sell33,000$100.79-0.33view
Carter Paul RutherfordEVP Commercial Ops 2014-12-01Sell2,000$100.020.44view
Whitley Richard JamesDirector 2014-12-01Sell5,000$100.190.27view
Cogan John FrancisDirector 2014-11-21Sell25,000$101.23-0.76view
MILLIGAN JOHN FPresident and COO 2014-11-07Sell146,895$107.37-6.44view
Alton Gregg HEVP, Corp & Med Affairs 2014-11-03Sell33,000$110.5-9.09view
Whitley Richard JamesDirector 2014-11-03Sell5,000$112.02-10.32view
MARTIN JOHN CChairman and CEO 2014-11-03Sell140,625$110.4-9view

Press Releases about GILD :

    Quarterly/Annual Reports about GILD:

    News about GILD:

    Articles On GuruFocus.com
    Druckenmiller Adds Healthcare Stocks to Portfolio Dec 15 2014 
    Weekly CFO Sells Highlight: Coco-Cola Co, Gilead Sciences Inc, AutoZone Inc. Dec 14 2014 
    Weekly Insider Sells Highlight: WAT, KO, GILD, AZO, MAS Dec 14 2014 
    T Rowe Price's Top Stakes for the Third Quarter Dec 09 2014 
    3 Strong Buys and Sells Dec 08 2014 
    Gilead Sciences' Recent Plunge Makes It One of The Hot Stocks To Buy Dec 01 2014 
    now Nov 29 2014 
    Weekly CFO Sells Highlight: Tableau Software Inc, Gilead Sciences Inc, Facebook Inc. Nov 16 2014 
    Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
    Gilead Sciences Can Sustain Its Impressive Performance in the Long Run Nov 11 2014 


    More From Other Websites
    Meet 5 Big Tech Stocks Expected To See Profits Surge Dec 16 2014
    Viekirax/Exviera vs. Harvoni: Clash of the Hep C Drugs 2015 Dec 16 2014
    Where is Santa rally? Dec 15 2014
    Gilead Sciences: What Its New Hire Means for Its Cancer Pipeline Dec 15 2014
    DMG MORI opens Global Headquarters in Winterthur New innovative technology centre in Switzerland Dec 15 2014
    Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology... Dec 15 2014
    Philippe C. Bishop, MD, to Join Gilead as Senior Vice President, Hematology and Oncology... Dec 15 2014
    Meet 5 Top Biotech Stocks Holding Up In Shaky Market Dec 13 2014
    These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market Dec 12 2014
    Gilead Sciences: Hep-C Scripts Go Down to the Wire Dec 12 2014
    Philadelphia transit system sues Gilead Sciences over $1,000-a-pill drug Dec 11 2014
    How Can Drugmakers Handle New Pricing Pressures? Dec 11 2014
    Six Reasons Gilead Sciences Will Head Higher in 2015 Dec 11 2014
    Gilead Sciences Bucks Trend In Biotech Short Interest Dec 11 2014
    Will AbbVie Undercut Gilead on Hepatitis C? Dec 11 2014
    Gilead Is Growing Fast And Its Stock Is Cheap Dec 11 2014
    Gilead Faces Suit Over Hepatitis Drug’s Price Dec 11 2014
    Gilead Sciences sued over hepatitis C drug's $1000-a-pill price tag Dec 10 2014
    Gilead faces lawsuit over hepatitis C drug pricing Dec 10 2014
    Gilead faces lawsuit over hepatitis C drug pricing Dec 10 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK